# Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient

> **NCT03153306** · PHASE4 · UNKNOWN · sponsor: **Hainan People's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** albumin

## Key facts

- **NCT ID:** NCT03153306
- **Lead sponsor:** Hainan People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-12
- **Final completion:** 2018-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03153306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03153306, "Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03153306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*